Back to Search
DAVID BATT, MD
MD
Rheumatology Physician
NPI: 1972547529IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
01030736A(IN)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
01030736(IN)01030736A(IN)
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1976
Research & Publications (16)
N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
PMID 15664858·Bioorg Med Chem Lett·2005
8-other
5-Amidinoindoles as dual inhibitors of coagulation factors IXa and Xa.
PMID 15454209·Bioorg Med Chem Lett·2004
4-observational
Synthesis of cis and trans isomers of an isoxazoline ring-hydroxylated metabolite of roxifiban, a platelet glycoprotein IIb/IIIa receptor antagonist.
PMID 11073629·J Org Chem·2000
7-preclinical
Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3).
PMID 10633037·J Med Chem·2000
8-other
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes.
PMID 19001434·Mol Cancer Ther·2008
7-preclinical
Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model.
PMID 18297306·Langenbecks Arch Surg·2008
7-preclinical
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists.
PMID 18160284·Bioorg Med Chem Lett·2008
8-other
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion.
PMID 17766837·Mol Cancer Ther·2007
8-other
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.
PMID 17418570·Bioorg Med Chem Lett·2007
7-preclinical
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
PMID 17363500·Mol Cancer Ther·2007
8-other
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
PMID 16951188·Cancer Res·2006
7-preclinical
Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
PMID 16551863·Clin Cancer Res·2006
7-preclinical
The effect of oxygenator membranes on blood: a comparison of two oxygenators in open-heart surgery.
PMID 14604250·Perfusion·2003
3-trial
A bending wave simulator for investigating directional vibration sensing in insects.
PMID 11508982·J Acoust Soc Am·2001
7-preclinical
Effects of the novel alphav integrin antagonist SM256 and cis-platinum on growth of murine squamous cell carcinoma PAM LY8.
PMID 10811994·Int J Oncol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1801 N SENATE BLVD, SUITE 315
INDIANAPOLIS, IN 46202 - Phone
- (317) 962-3500
Quick Facts
- NPI
- 1972547529
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 50
- Publications
- 16
Are you this provider?
Claim Your Profile